Ib Abildgaard Jacobsen: Clinical Trials

2 trials sponsored by Ib Abildgaard Jacobsen, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1
Phase 41Completed 1

Follow Ib Abildgaard Jacobsen: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Amiloride for Resistant Hypertension
Amiloride - Hypertension, Type 2 Diabetes Mellitus
Phase 4CompletedIb Abildgaard Jacobsen802010-11-012014-04-24
The Effect of Spironolactone on Blood Pressure in Type-2 Diabetics With Resistant Hypertension
spironolactone, placebo - Arterial Hypertension, Hypertension, Resistant to Conventional Therapy
Phase 3CompletedIb Abildgaard Jacobsen1192010-03-012014-05-08

Conditions studied

Hypertension (2)  ·  Diabetes Mellitus (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Hypertension Resistant to Conventional Therapy (1)

Interventions

Amiloride (1)  ·  Spironolactone (1)

Countries

Denmark (1)

Top investigators

Ib A Jacobsen, DMSc (2)

Results publications

PMID 24739800, PMID 33107592

NIH funding

2009 (1)